Feb 26, 2024 / 10:00PM GMT
Operator
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma Fourth Quarter 2023 conference call. During the presentation, (Operator instructions) Also, today's conference call is being recorded.
And now I'd like to turn the call over to Rick Winningham, Chief Executive Officer. Please go ahead, sir.
Rick Winningham Theravance Biopharma - Inc. - Chairman & CEO
Yeah, good afternoon, everyone, and thank you for joining the Theravance Biopharma Fourth Quarter and Full Year 2023 earnings results conference call. Turning to slide 2, I'll remind you that this call will contain forward-looking statements that involve risks and uncertainties, including statements about our development pipeline, expected benefits of our product candidates, anticipated timing of clinical trials, regulatory filings and expected financial results. Information containing factors that could cause results to differ materially from our forward-looking statements is described further in our filings with the SEC.
Today, I'm joined by Ãine
Q4 2023 Theravance Biopharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot